If skin irritation occurs, discontinue use
Top-line results of the Phase 2 trial demonstrated metopimazine led to a 40% reduction in the incidence of nausea and a 56% reduction in frequency of vomiting
Ding F, Wang Q, Xie C, Wang M, Zhang L, Gao M, Yang Z, Ma J, Shi X, Chen W, Duan S, Yuan P, Li Y, Ma X, Wu Y, Liu J, Feng X, Cheng Q, Wang Z, Li X, Huang J
International Journal of Molecular Sciences Obeid R, et al
"By bringing the API manufacturing domestic, we can control far more of the process end to end, giving us advantages in quality and purity and reliability and ultimately, in brand trust that I think will be incredibly difficult for others to match and I think increasingly important as these treatments and therapeutics become more mass market," Dudum said during the call